Agilysys, Inc.
NASDAQ:AGYSSoftware - Application
-$0.39 today
- Market cap
- $3.37B
- Beta
- 0.40
- P/E (TTM)
- 63.1
- EPS (TTM)
- $1.38
Volume 0.28M
Average 0.35M
AGYS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Agilysys, Inc.NASDAQ: AGYS
Research & Development · Q2 FY2027 · quarter ended Sep 2026
Research & development grows, but more slowly than its trailing trend
Q2 FY2027 research & development of $19.85M rose 11.3% year over year, behind the +16.1% change in trailing-twelve-month research & development. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +13.1% a year.
Context
- Research & development amounted to 22.8% of revenue in FY2026, up 0.1 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +11.3% toward the trailing-twelve-month pace of +16.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 72.74M USD
- Year-over-year change
- +16.6%
- 4-year CAGR
- +11.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 72.74M | +16.6% |
| FY2025 | 2025-03-31 | 62.41M | +10.0% |
| FY2024 | 2024-03-31 | 56.74M | +12.9% |
| FY2023 | 2023-03-31 | 50.26M | +8.5% |
| FY2022 | 2022-03-31 | 46.33M | — |
Research & Development vs competitors
How AGYS compares with its peers on the latest reported figures
- AGYS's LTM Sep 2026 research & development of $77.56M is the lowest of the 4 companies compared; the peer median is $126.48M.
- Its year-over-year change of +16.1% is the 2nd highest of 3, against a peer median of +11.5%.
- Research & development amounts to 22.5% of revenue for AGYS, versus a peer median of 17.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $538.72M | — | -13.4% | 19.0% | |
| LTM Mar 2026 | $126.48M | +5.1% | -3.5% | 10.3% | |
| LTM Mar 2026 | $83.98M | +17.9% | +18.9% | 17.7% | |
| LTM Sep 2026 | $77.56M | +16.1% | +13.1% | 22.5% | |
| Peer median (excluding AGYS) | $126.48M | +11.5% | -3.5% | 17.7% | |
Competitors are the stored peer set for AGYS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 162.64M | 198.07M | 237.46M | 275.62M | 319.31M |
| Cost of Revenue | 61.1M | 77.25M | 93.21M | 103.64M | 121.81M |
| Gross Profit | 101.53M | 120.82M | 144.26M | 171.99M | 197.5M |
| Gross Margin | 62.4% | 61.0% | 60.7% | 62.4% | 61.9% |
| Research & Development | 46.33M | 50.26M | 56.74M | 62.41M | 72.74M |
| Selling, General & Admin | 42.46M | 53.39M | 64.72M | 73.98M | 81.99M |
| Operating Expenses | 95.21M | 107.94M | 128.5M | 149.4M | 157.24M |
| Depreciation & Amortization | 3.86M | 3.67M | 5.26M | 8M | 10.25M |
| EBITDA | 10.39M | 19.44M | 25.95M | 35.16M | 59.15M |
| EBITDA Margin | 6.4% | 9.8% | 10.9% | 12.8% | 18.5% |
| Operating Income | 6.32M | 12.88M | 15.75M | 22.59M | 40.15M |
| Operating Margin | 3.9% | 6.5% | 6.6% | 8.2% | 12.6% |
| Interest Income | 59K | 2.19M | 5.08M | 3.78M | 1.99M |
| Interest Expense | 12K | 0 | 0 | 1.53M | 493K |
| Other Income / Expenses | 192K | 2.89M | 4.93M | 3.04M | 8.26M |
| Income Before Tax | 6.51M | 15.76M | 20.68M | 25.64M | 48.41M |
| Pre-Tax Margin | 4.0% | 8.0% | 8.7% | 9.3% | 15.2% |
| Income Tax Expense | 33K | 1.18M | (65.51M) | 2.41M | 9.62M |
| Net Income | 6.48M | 14.58M | 86.2M | 23.23M | 38.79M |
| Net Margin | 4.0% | 7.4% | 36.3% | 8.4% | 12.1% |
| EPS (Basic) | 0.19 | 0.52 | 3.31 | 0.84 | 1.39 |
| EPS (Diluted) | 0.18 | 0.49 | 3.17 | 0.82 | 1.36 |
| Weighted Avg Shares | 24.36M | 24.69M | 25.67M | 27.52M | 28.05M |
| Weighted Avg Shares (Diluted) | 25.48M | 25.93M | 26.84M | 28.26M | 28.42M |
Agilysys, Inc.
NASDAQ:AGYS
Intrinsic Alpha fair value
Locked
Current Price
$119.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.